Cellcura ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cellcura ASA's CEO Lars Bredahl Steps Down; Company Appoints Tore Kvam Acting CEO
Cellcura ASA announced that Lars Bredahl and the Board of Directors in the Company have jointly decided, with effect from December 21, 2012, that Mr. Bredahl will step down as Chief Executive Officer (CEO) for the Company due to different views of the future development for the Company. Tore Kvam (Chief Financial Officer) will be acting CEO from December 21, 2012 until new appointment is made. The search for new CEO will start immediately.
Latest Developments for Cellcura ASA
Latest Key Developments in Medical
- Pro-Dex Inc announces record date for planned rights offering
- Vexim SA announces results of study into use of Spinejack for vertebral compression factors
- Cardiovascular Systems Inc receives FDA clearance for low profile, 60cm diamondback devices designed to expand the treatment of peripheral artery disease
- BenQ Medical Technology Corp announces FY 2013 dividend payment
- Share this
- Digg this